×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Is Clene (CLNN) Stock Outpacing Its Medical Peers This Year?
Yahoo Life UK
Here is how Clene Inc. (CLNN) and The Cooper Companies (COO) have performed compared to their sector so far this year.
2 days ago
Analyst Scoreboard: 6 Ratings For Clene - Clene (NASDAQ:CLNN)
Benzinga
6 analysts have shared their evaluations of Clene. CLNN+2.70%. + Free Alerts. during the recent three months, expressing a mix of bullish...
4 days ago
Gold nanoparticles reverse brain deficits in multiple sclerosis, Parkinson's
UT Southwestern Medical Center
Gold nanocrystals suspended in a water buffer represent a novel therapeutic agent developed by Clene Nanomedicine for neurodegenerative...
3 months ago
Clene's neurodegenerative disease drug shows promise
biopharma-reporter.com
Biopharma company Clene has published 'impactful' new research into CNM-Au8, its investigational drug in development for the treatment of...
2 months ago
Clene (NASDAQ:CLNN) Given “Buy” Rating at Benchmark
Defense World
Read Clene (NASDAQ:CLNN) Given “Buy” Rating at Benchmark at Defense World.
4 days ago
The Globe and Mail
The Globe and Mail
Clene (NASDAQ: CLNN) has innovated CNM-Au8(R), an oral nanotherapeutic designed to revitalize the brain's mitochondrial function,...
4 days ago
FDA Denies Accelerated Approval for Clene’s ALS Candidate
BioSpace
Clene disclosed Thursday the FDA has determined that biomarker Neurofilament Light Chain reduction in its Phase II programs “were...
5 months ago
Clene First Quarter 2024 Earnings: Misses Expectations
Simply Wall Street
Clene ( NASDAQ:CLNN ) First Quarter 2024 Results Key Financial Results Net loss: US$11.1m (loss narrowed by 5.9% from...
3 weeks ago
Clene Inc. (CLNN) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Life UK
Clene Inc. (CLNN) delivered earnings and revenue surprises of 39.13% and 228.30%, respectively, for the quarter ended September 2022.
1 day ago
Research identifies ways CNM-Au8 can effectively reach the brain
ALS News Today
Research has identified certain properties of CNM-Au8 that help it reach the brain to exert its therapeutic effects in ALS patients.
2 months ago